Estradiol 2mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Estradiol

Available from:

Viatris UK Healthcare Ltd

ATC code:

G03CA03

INN (International Name):

Estradiol

Dosage:

2mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 06040101

Patient Information leaflet

VERY RARE (IN LESS THAN 1 IN 10,000 PATIENTS TREATED, NOT KNOWN
(CANNOT BE ESTIMATED FROM THE AVAILABLE DATA)):
-
reduction in red blood cells which can make the skin pale and
cause weakness or breathlessness (anaemia)
If unscheduled bleeding occurs after some time on HRT, you should
contact your doctor. If unscheduled bleeding continues after
stopping HRT, it may be necessary to perform tests to exclude
disease of the endometrium (the lining of the uterus).
Changes can occur in the levels of certain proteins and hormones
in the blood. The action of the hormones in the body is not affected.
You should tell your doctor that you are taking HRT if you are to
have a blood test.
The following side effects have been reported in association with
estradiol treatment (frequency unknown):

fibroids get bigger (growth in the womb increase)

chorea (muscle twitches)

worsening of fits (epilepsy)

blood clots in the arteries (arterial thromboembolism)

inflammation of the pancreas (pancreatitis) in women with pre-
existing high levels of certain blood fats (hypertriglyceridemia)

a condition where gastric juices, containing acid, travel back
from the stomach into the oesophagus (gastroesophageal reflux
disease) symptoms include heartburn

liver disorders, which may include jaundice (yellowing of the
skin)

discolouration of the skin especially of the face or neck known
as ‘’pregnancy patches’’ (chloasma)

rash with target shaped reddening or sores (erythema
multiforme)

skin discolouration (purpura)

swelling of the skin around face and throat (angioedema)

urinary incontinence

painful/lumpy breasts (fibrocystic breast disease)
REPORTING OF SIDE EFFECTS
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. You can
also report side effects directly via the Yellow Card Scheme at:
www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in
the GOOGLE PLAY or APPLE APP STORE. By reporting side effects,
yo